DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,050,000 | +9.2% | 3,500,000 | 0.0% | 0.30% | 0.0% |
| Q1 2023 | $20,195,000 | -13.4% | 3,500,000 | +54.0% | 0.30% | -14.1% |
| Q4 2022 | $23,312,998 | -37.3% | 2,272,222 | +2.3% | 0.35% | -49.3% |
| Q3 2022 | $37,156,000 | +19.4% | 2,222,222 | 0.0% | 0.69% | +11.5% |
| Q2 2022 | $31,111,000 | -13.3% | 2,222,222 | 0.0% | 0.62% | -6.1% |
| Q1 2022 | $35,889,000 | +2.5% | 2,222,222 | +35.8% | 0.66% | +9.9% |
| Q4 2021 | $35,029,000 | +62.4% | 1,636,100 | +11.4% | 0.60% | +75.8% |
| Q3 2021 | $21,570,000 | -18.3% | 1,468,318 | 0.0% | 0.34% | -26.1% |
| Q2 2021 | $26,410,000 | -33.5% | 1,468,318 | 0.0% | 0.46% | -33.1% |
| Q1 2021 | $39,702,000 | – | 1,468,318 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |